Shan Zhao

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

University of Arkansas

Also affiliated: Shandong University (2015–2019); Guangxi Medical University (2012–2014); Hefei University of Technology (2023); University of Zurich (2024); ETH Zurich (2024); Institute for Biomedical Engineering (2025); Institute of Plant Protection (2023–2024); Shandong Academy of Agricultural Sciences (2023–2024); First Affiliated Hospital of GuangXi Medical University (2012–2014); Beijing Institute of Graphic Communication (2018); Second Affiliated Hospital of Nanjing Medical University (2024); First Hospital of China Medical University (2023); Ministry of Agriculture and Rural Affairs (2023–2024); Shandong Provincial QianFoShan Hospital (2015–2019); Tumor Hospital of Guangxi Medical University (2013–2015); Zhejiang Yuexiu University (2022); Beihang University (2024); Nanjing Medical University (2024); China Medical University (2023)

Faculty Researcher

13 h-index 22 pubs 780 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Shan Zhao's research focuses on understanding the molecular mechanisms underlying cancer, particularly in relation to gene expression regulation and cellular processes. Their work has investigated the role of microRNAs (miRNAs) and other regulatory molecules in neoplastic gene expression, cell proliferation, and tumor progression. Zhao has also explored the potential of specific proteins, such as IGF2BPs, as key regulators in cancer cell functions, including adaptation to hypoxia, metabolism, and the modulation of the tumor microenvironment. Publications from Zhao's group have examined multiplex protein imaging in tumor biology and explored stratification systems for breast cancer based on cellular and architectural features. The researcher's work has been cited 755 times, with an h-index of 13 across 22 publications.